0000899243-21-009963.txt : 20210304
0000899243-21-009963.hdr.sgml : 20210304
20210304192423
ACCESSION NUMBER: 0000899243-21-009963
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210302
FILED AS OF DATE: 20210304
DATE AS OF CHANGE: 20210304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farwell Wildon
CENTRAL INDEX KEY: 0001847941
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39509
FILM NUMBER: 21716008
MAIL ADDRESS:
STREET 1: C/O DYNE THERAPEUTICS, INC.
CITY: 830 WINTER STREET
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dyne Therapeutics, Inc.
CENTRAL INDEX KEY: 0001818794
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 364883909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 786-8230
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-02
0
0001818794
Dyne Therapeutics, Inc.
DYN
0001847941
Farwell Wildon
C/O DYNE THERAPEUTICS, INC.
830 WINTER STREET
WALTHAM
MA
02451
0
1
0
0
Chief Medical Officer
Common Stock
2021-03-02
4
A
0
50000
0.00
A
50000
D
Stock Option (right to buy)
17.77
2021-03-02
4
A
0
250000
0.00
A
2031-03-01
Common Stock
250000
250000
D
Consists of shares of Common Stock issuable under 50,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on March 1, 2022.
This option was granted on March 2, 2021. The shares underlying the option are scheduled to vest over four years, with 25% of the shares vesting on March 1, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
/s/ Richard Scalzo, Attorney-in-Fact
2021-03-04